Literature DB >> 18326534

Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides.

K Tilleman1, K Van Steendam, T Cantaert, F De Keyser, D Elewaut, D Deforce.   

Abstract

OBJECTIVES: To investigate the presence and characteristics of citrullinated vimentin in protein extracts of inflamed synovial tissue.
METHODS: Cytosolic protein extracts obtained from RA (n = 14) and SpA patients (n = 14) were analysed by gel electrophoresis and western blotting. Citrullinated vimentin isoforms were visualized by a combination of anti-modified citrulline (AMC) staining and anti-vimentin detections (V9, H-84). This was subsequently confirmed by immunoprecipitation. Autoantibody detection was verified using sera obtained form RA (n = 6) and SpA (n = 6) patients.
RESULTS: A specific cluster of spots displayed on the 2D gel images of cytosolic synovial tissue extracts, was identified by mass spectrometry as vimentin. Interestingly, our results suggested that these isoforms could be the result of caspase cleavage. In addition, these cleaved forms of vimentin were found to be citrullinated in synovial cytosolic protein extracts of inflammatory arthritides, mainly in RA patients. Caspase-3 is able to cleave vimentin at amino acid 85. Western blot analysis with a specific antibody against amino acids 1-84 of vimentin (H-84) confirmed that the citrullinated isoforms of vimentin were lacking this part of the protein. These results were also confirmed by immunoprecipitation of vimentin derived from cytosolic protein extracts of RA and SpA patients. Furthermore, the presence of autoantibodies against these citrullinated processed forms of vimentin was found to be predominantly associated with RA patients.
CONCLUSIONS: These findings show the presence of processed citrullinated vimentin in inflammatory arthritides, mainly in RA and suggest a possible origin of the ACPA immune response in RA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18326534     DOI: 10.1093/rheumatology/ken077

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  25 in total

1.  In ACPA-positive RA patients, antibodies to EBNA35-58Cit, a citrullinated peptide from the Epstein-Barr nuclear antigen-1, strongly cross-react with the peptide β60-74Cit which bears the immunodominant epitope of citrullinated fibrin.

Authors:  M Cornillet; E Verrouil; A Cantagrel; G Serre; L Nogueira
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

2.  Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins.

Authors:  Katleen Van Steendam; Kelly Tilleman; Marlies De Ceuleneer; Filip De Keyser; Dirk Elewaut; Dieter Deforce
Journal:  Arthritis Res Ther       Date:  2010-07-07       Impact factor: 5.156

3.  The amount of citrullinated proteins in synovial tissue is related to serum anti-cyclic citrullinated peptide (anti-CCP) antibody levels.

Authors:  Elizabeth Olivares-Martínez; Diego F Hernández-Ramírez; Carlos A Núñez-Álvarez; Antonio R Cabral; Luis Llorente
Journal:  Clin Rheumatol       Date:  2015-08-09       Impact factor: 2.980

Review 4.  Chemical and biological methods to detect post-translational modifications of arginine.

Authors:  Daniel J Slade; Venkataraman Subramanian; Jakob Fuhrmann; Paul R Thompson
Journal:  Biopolymers       Date:  2014-02       Impact factor: 2.505

5.  Anti-vimentin antibodies: a unique antibody class associated with therapy-resistant lupus nephritis.

Authors:  Andrew J Kinloch; Matthew D Cascino; Jian Dai; Rene S Bermea; Kichul Ko; Margaret Vesselits; Leonard L Dragone; Nirit Mor Vaknin; Maureen Legendre; David M Markovitz; Michael K Okoreeh; Michael J Townsend; Marcus R Clark
Journal:  Lupus       Date:  2020-03-26       Impact factor: 2.911

6.  Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis.

Authors:  Hirofumi Shoda; Keishi Fujio; Mihoko Shibuya; Tomohisa Okamura; Shuji Sumitomo; Akiko Okamoto; Tetsuji Sawada; Kazuhiko Yamamoto
Journal:  Arthritis Res Ther       Date:  2011-11-22       Impact factor: 5.156

7.  Identification of novel autoantigen in the synovial fluid of rheumatoid arthritis patients using an immunoproteomics approach.

Authors:  Sagarika Biswas; Saurabh Sharma; Ashish Saroha; D S Bhakuni; Rajesh Malhotra; Muzna Zahur; Michael Oellerich; Hasi R Das; Abdul R Asif
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

Review 8.  Citrullination and PAD Enzyme Biology in Type 1 Diabetes - Regulators of Inflammation, Autoimmunity, and Pathology.

Authors:  Mei-Ling Yang; Fernanda M C Sodré; Mark J Mamula; Lut Overbergh
Journal:  Front Immunol       Date:  2021-06-01       Impact factor: 7.561

9.  Greater prevalence of seropositivity for anti-cyclic citrullinated peptide antibody in unaffected first-degree relatives in multicase rheumatoid arthritis-affected families.

Authors:  Seong-Kyu Kim; Jisuk Bae; Hwajeong Lee; Ji Hun Kim; Sung-Hoon Park; Jung-Yoon Choe
Journal:  Korean J Intern Med       Date:  2012-12-28       Impact factor: 2.884

10.  Are antibodies to fine specificities of citrullinated peptides/proteins useful for stratification of rheumatoid arthritis patients?

Authors:  Leonor Nogueira; Emilie Parra; Margaux Larrieu; Evelyne Verrouil; Martin Cornillet
Journal:  Clin Transl Immunology       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.